Medicare Enrolled

Dr. Joseph Biase, MD

Urology Physician · Boynton Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
10151 ENTERPRISE CENTER BLVD, Boynton Beach, FL 33437
5617379191
In practice since 2005 (20 years)
NPI: 1962499319 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Biase from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Biase? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Biase

Dr. Joseph Biase is an urology physician in Boynton Beach, FL, with 20 years in practice. Based on federal Medicare data, Dr. Biase performed 14,710 Medicare services across 6,116 unique beneficiaries.

Between the years covered by Open Payments, Dr. Biase received a total of $2,197 from 19 pharmaceutical and/or device companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Biase is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 8% volume in FL$ $2,197 industry payments

Medicare Practice Summary

Medicare Utilization ↗
14,710
Medicare services
Top 8% in FL for urology physician
6,116
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~736 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
BCG treatment for bladder cancer4,500$2$6
Automated urinalysis2,279$2$9
Office visit, established patient (30-39 min)1,806$102$200
Office visit, established patient (20-29 min)1,393$67$150
Urinalysis for bacteria1,195$29$35
Bladder ultrasound after voiding819$8$130
Drug injection, under skin or into muscle479$11$50
Hospital follow-up visit, moderate complexity337$66$150
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional307$18$50
New patient office visit (45-59 min)247$126$300
Insertion of temporary bladder tube202$36$100
Leuprolide acetate (for depot suspension), 7.5 mg177$137$650
Diagnostic exam of bladder and urethra using an endoscope130$196$400
Hospital follow-up visit, high complexity116$100$200
Initial hospital admission, high complexity105$145$300
Instillation of anti-cancer drug into bladder101$72$300
Dilation of urethra using an endoscope81$269$1,200
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle59$28$80
Simple bladder irrigation and/or instillation52$55$200
Electronic assessment of bladder emptying48$11$200
Simple insertion of temporary bladder tube40$50$200
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and34$43$150
Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope29$102$1,500
Insertion of tube into ureter using an endoscope through bladder area28$52$900
Insertion of stent in ureter using an endoscope22$91$818
Office visit, established patient (10-19 min)19$42$80
Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope18$267$500
Ultrasound scan of pelvic region through rectum18$112$300
Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope13$340$800
Crushing of stone of ureter with insertion of stent using an endoscope12$329$1,200
Destruction and/or removal of large growth of bladder using an endoscope11$331$1,500
Biopsy of prostate gland11$203$400
Complete ultrasound scan of pelvis11$88$200
Ultrasonic guidance for needle placement11$48$200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
9.5% medium
90.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,197
Total received (2018-2024)
Avg $314/year across 7 years
Bottom 38% in FL for urology physician
19
Companies
67
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,197 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$766
2023
$127
2022
$301
2021
$319
2020
$233
2019
$291
2018
$159

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$581
Rochester Medical Corporation
$249
Janssen Biotech, Inc.
$178
Myriad Genetic Laboratories, Inc.
$154
Terumo Medical Corporation
$142
Laborie Medical Technologies Corp.
$136
Axonics, Inc.
$134
PFIZER INC.
$125
AstraZeneca Pharmaceuticals LP
$119
Olympus America Inc.
$84
C. R. BARD, INC. & SUBSIDIARIES
$68
C. R. Bard, Inc. & Subsidiaries
$38
Becton, Dickinson and Company
$38
Ferring Pharmaceuticals Inc.
$36
Sumitomo Pharma America, Inc.
$27
Hitachi Healthcare Americas Corp.
$26
Boston Scientific Corporation
$23
BOSTON SCIENTIFIC CORPORATION
$20
Coloplast Corp
$17
Top 3 companies account for 45.9% of total payments
Associated products mentioned in payments ›
AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · Axonics r-SNM System · Bard Urinary Drainage Bag · ERLEADA · Erleada · GLIDESHEATH SLENDER · LYNPARZA · MYRBETRIQ · Myrbetriq · ORGOVYX · Olympus Cysto-Resection · Optilume BPH Drug Coated Balloon Catheter · PROLARIS · Soltive · TITAN · UGN Laser Capital · VESICARE · XTANDI · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $15 per 100 Medicare services performed
Looking for a urology physician in Boynton Beach?
Compare urology physicians in the Boynton Beach area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
103
Per 100K population
6.8
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
3.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Biase is a clinical cardiology specialist, with above-average Medicare volume (top 8% in FL), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Biase experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Biase performed 4,500 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Biase receive payments from pharmaceutical companies?
Yes. Dr. Biase received a total of $2,197 from 19 companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Biase's costs compare to other urology physicians in Boynton Beach?
Dr. Biase's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Biase) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →